Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRCT Endpoints in Pulmonary Sarcoidosis
NCT03324503Completed
- Sponsor
- Celgene Corporation
- Start
- Dec 2017
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Open-label, single-arm trial of prednisone and prednisolone in pulmonary sarcoidosis, sponsored by Celgene Corporation. Primary endpoint: Change from baseline in high-resolution computed tomography (HRCT) at 8 weeks. Started Dec 2017; status: completed.
02
Drugs
prednisoneprednisolone
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT03324503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324503.